| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JURO.2008.03.053 |
| P698 | PubMed publication ID | 18485398 |
| P50 | author | Ewout W. Steyerberg | Q37828851 |
| Michael W Kattan | Q60653077 | ||
| P2093 | author name string | Fritz H Schröder | |
| J Stephen Jones | |||
| Fei Dong | |||
| Eric A Klein | |||
| Andrew J Stephenson | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 150-4; discussion 154 | |
| P577 | publication date | 2008-05-15 | |
| P1433 | published in | Journal of Urology | Q15709979 |
| P1476 | title | Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice | |
| P478 | volume | 180 |
| Q92726559 | A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA) |
| Q37307609 | Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository |
| Q43914035 | Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study |
| Q90108698 | Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy |
| Q39988569 | Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information |
| Q37422990 | Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer |
| Q62660574 | Editorial Comment |
| Q37988363 | Formalized prediction of clinically significant prostate cancer: is it possible? |
| Q35875135 | Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group. |
| Q36300978 | Integrated predictive model for prostatic cancer using clinical, laboratory and ultrasound data |
| Q46873257 | Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer |
| Q26996501 | Management of low (favourable)-risk prostate cancer |
| Q37457676 | Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer |
| Q49861775 | Prediction of Prostate Cancer Risk Among Men Undergoing Combined MRI-targeted and Systematic Biopsy Using Novel Pre-biopsy Nomograms That Incorporate MRI Findings |
| Q57461674 | Prediction of prostate cancer by deep learning with multilayer artificial neural network |
| Q37526813 | Predictive models in diagnosing indolent cancer. |
| Q35722781 | Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer |
| Q38211619 | Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study |
| Q33567004 | Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery |
| Q33395534 | Prostate cancer--to screen, or not to screen, is that the question? |
| Q59649650 | Reply |
| Q41599088 | Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer |
| Q57259807 | Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study |
| Q84567939 | Selective detection of aggressive prostate cancer |
| Q36421154 | Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial |
| Q26849794 | The role of magnetic resonance imaging in the diagnosis and management of prostate cancer |
| Q39532018 | Why can't nomograms be more like Netflix? |
Search more.